- Home
- IMAB
IMAB
I-MAB
as 04-01-2025 4:00pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as I-MAB IMAB prepares to release earnings report on 08 Apr 2025.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | 2020 |
| Target Price: | $7.00 | AVG Volume (30 days): | 197.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.76 - $2.00 | Next Earning Date: | 04-08-2025 |
| Revenue: | $569,464 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest I-MAB News
IMAB Breaking Stock News: Dive into IMAB Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
I-Mab to Present at 24th Annual Needham Virtual Healthcare Conference
MT Newswires
12 days ago
I-Mab Gets Nasdaq Noncompliance Notice on Bid Price Requirement
GlobeNewswire
12 days ago
I-Mab Announces Receipt Of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
a month ago
I-Mab Announces Accelerated Givastomig Phase 1b Study Progress
GlobeNewswire
a month ago
I-Mab to Participate in Leerink Partners Global Healthcare Conference
GlobeNewswire
2 months ago
I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
PR Newswire
3 months ago
I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member
Simply Wall St.
3 months ago
US Penny Stocks To Watch In January 2025
Compare IMAB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IMAB I-MAB - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.